We are live on ! Find out more
ESPR

ESPERION THERAPEUTICS INC
ESPR

Delisted

ESPR was delisted on the 10th of February, 2004.

1 hedge funds and large institutions have $49K invested in ESPERION THERAPEUTICS INC in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
SFPIA
1
Stevens First Principles Investment Advisors
California
$49K +$49K +600 New

ESPR Hedge Fund Activity: Q2 2015 in Review

1 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in ESPERION THERAPEUTICS INC (ESPR) for Q2 2015, worth a combined $49K.

Buyers outnumbered sellers: 1 fund opened new ESPR positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Stevens First Principles Investment Advisors, opening a new position worth an estimated $49K.

  • 1 institutional investor held ESPERION THERAPEUTICS INC (ESPR) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $49K of ESPERION THERAPEUTICS INC stock for Q2 2015.
  • 1 fund opened new ESPERION THERAPEUTICS INC positions in Q2 2015 and 0 closed out, a net change of +1 holder.
  • The largest ESPERION THERAPEUTICS INC buyer in Q2 2015 was Stevens First Principles Investment Advisors, an estimated $49K added.

Based on aggregated 13F filings for Q2 2015.